The decision was influenced by the positive recommendation from the EMA’s Committee for Medicinal Products for Human Use.

Merck MRK announced that the European Commission (“EC”) has approved its 21-valent pneumococcal conjugate vaccine (“PCV”), ...

Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or ...

Approves Merck’s CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and ...

Childhood vaccinations have not recovered from the slump that happened after the pandemic, according to new research.

In an attempt to strike a pitch-perfect tone with Generation X, Pfizer has recruited Elizabeth Banks as the face of a new ...

Merck & Co. has won approval from the European Commission of its Capvaxive pneumococcal disease vaccine for adults. The Rahway, N.J., drugmaker on Wednesday said the approval covers the 21-valent ...

Vaccine series completion for rotavirus, DTaP, PCV at 12 months was highest in January 2020 and remained lower in October 2023.

Even if you received childhood vaccinations it’s important to consult a doctor to determine whether you need a booster shot ...

These vaccines include those for: COVID-19 the flu pneumococcal disease Tdap herpes zoster (shingles) If you have COPD, talk with a doctor about your current vaccinations. They can let you know ...

The Centers for Disease Control and Prevention has added a new vaccine recommendation for adults. Those as young as age 50 should get vaccinated against pneumococcal pneumonia, the CDC said. The ...